Theragenics (TGX) on the up and up Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theragenics (TGX) on the up and up

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Solid who wrote (889)	6/24/1998 4:00:00 PM
From: Tulvio Durand	Read Replies (1) of 1055

THRX director of IR just told me that Monday's drop was an over-reaction to analyst (Dain) reducing earnings Q estimate from 0.11 to 0.10. There's been no fundamental change in THRX business. A fifth cyclotron has been added which will add to earnings in 3rd Q. Six more cyclotrons will come online by the end of 1999 for a total 14 cyclotrons. THRX is suing IBT of Belgium for theft of secrets (by former THRX employee) relating to mfg. of Paladium 103 seeds. THRX has plenty of cash on hand, $38 million at start of year, and a line of credit for another $30 million. Sees no significant competitive threat from other companies (INIS, IBT, NASI), nor from anti-cancer drugs (that seem to work only in rats). Mine was about the 200th call he has returned from investors since Monday. Tulvio

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next